Arovella Therapeutics Limited

Vision

Arovella Therapeutics intends to be a world leader as a biotechnology company helping people live longer and healthier lives.

Mission

The company will develop its existing products and look to acquire additional platforms we believe have an impact on the treatment of cancer and conditions that affect the central nervous system.

Values

Patient-Centric
Data-Driven and Milestone Focused
Accountable, Honest and Act with Integrity
Persistence and Never Give Up

ASX Code
ALA

Sector
Pharmaceuticals- Biotechnology & Life Sciences

Website
https://www.arovella.com/

Spotlight Videos

Arovella Therapeutics (ASX: ALA) – Tackling blood cancers and solid tumours

Arovella Therapeutics (ASX:ALA) partners with Imugene (ASX:IMU)

Arovella Therapeutics (ASX: ALA) – Webinar Presentation

All Arovella Therapeutics Limited Content

News

Arovella Therapeutics (ASX: ALA) – Tackling blood cancers and solid tumours

November 15, 2022 - by Finance News Network

Arovella Therapeutics Limited Managing Director and CEO Dr Michael Baker provides an update on what's been happening at the biotech company.

Arovella Therapeutics (ASX:ALA) partners with Imugene (ASX:IMU)

September 30, 2022 - by Finance News Network

Arovella Therapeutics Limited (ASX:ALA) Managing Director and CEO Michael Baker discusses the company's collaboration with Imugene to combine therapies.

Arovella Therapeutics (ASX: ALA) – Webinar Presentation

February 21, 2022 - by Company News

Dr Michael Baker - CEO & MD - Arovella develops products and acquires additional platforms that have an impact on the treatment of cancer and conditions that affect the central nervous system.